Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Volume VII No. 15 - October 23, 2000

Beware What Your Lab Competitor is Doing!

TODAY I WOULD LIKE TO SPEAK SPECIFICALLY to hospital lab administrators and owners of independent commercial laboratories. I would like to offer some friendly counsel: it’s time to pay careful attention to the most successful of your laboratory competitors. Undeniable evidence is mounting that traditional clinical laboratory management methods are inferior to new models of …

Beware What Your Lab Competitor is Doing! Read More »

To access this post, you must purchase The Dark Report.

AML & Dynacare Next To Try a Public Offering

CEO SUMMARY: There will be plenty of competition for investors’ dollars this fall. American Medical Laboratories and Dynacare will join Specialty Laboratories in the effort to place an initial public offering (IPO). Three laboratory companies coming to market during the same period will certainly demonstrate whether professional investors truly believe that good times lie ahead …

AML & Dynacare Next To Try a Public Offering Read More »

To access this post, you must purchase The Dark Report.

IPO Is Major Strategy For American Med Labs

CEO SUMMARY: Since its acquisition in 1997, American Medical Laboratories’ fast growth was funded by heavy borrowing. Now this Virginia-based lab company needs to raise additional capital so it can restructure its debt and lay a foundation for the next cycle of growth. Its initial public offering of common stock will need to compete with …

IPO Is Major Strategy For American Med Labs Read More »

To access this post, you must purchase The Dark Report.

ISO 9000 Growing Across Lab Divisions of Quest Diagnostics

CEO SUMMARY: Currently the American healthcare system is struggling to evolve away from its “cottage industry” roots and adopt modern corporate management methods. Within the clinical laboratory industry, Quest Diagnostics Incorporated has staked out the high ground. Its strategic objective is to infuse the entire laboratory company with knowledge of specific management methods commonly known …

ISO 9000 Growing Across Lab Divisions of Quest Diagnostics Read More »

To access this post, you must purchase The Dark Report.

Intel & iMcKesson Fund Study Of Doctor-Patient Email System

IT’S CONSUMER DEMAND which motivated Intel Corporation and iMcKesson LLC to fund a study of how state-of-the-art email connectivity benefits physicians and their patients. The study, announced on October 11, will be conducted at the University of Michigan Health System (UMHS) in Ann Arbor Michigan. Led by two internists, Steven J. Katz, M.D., M.P.H. and …

Intel & iMcKesson Fund Study Of Doctor-Patient Email System Read More »

To access this post, you must purchase The Dark Report.

Advanced Health Technologies, ProxyMed, WebMD, ePhysician, Data Critical Corp.

Editor’s Note: There is a major push by many well-funded companies to convert lab test ordering and results reporting onto Web-enabled systems. Here’s a sampling of what some companies are attempting to accomplish. AHT, MAKER OF DR.CHART, FILES BANKRUPTCY AND IS ACQUIRED BY BIOSHIELD FOLLOWING A SUMMER OF SQUABBLES with would-be acquirer Bioshield Technologies, AHT …

Advanced Health Technologies, ProxyMed, WebMD, ePhysician, Data Critical Corp. Read More »

To access this post, you must purchase The Dark Report.

Dynacare Sets Sights On Raising $89 Million

CEO SUMMARY: Throughout the 1990s, Dynacare weathered the wholesale restructuring of health services in several key Canadian provinces where it operates. In the United States, it sought to build a national base of lab testing even as lab consolidation raged and capitated managed care contracts were common. Having survived in both countries, Dynacare now wants …

Dynacare Sets Sights On Raising $89 Million Read More »

To access this post, you must purchase The Dark Report.

“October 23, 2000 Intelligence: Late Breaking Lab News”

Get ready for the stock market to begin creating multi-millionaires from today’s generation of commercial laboratory executives. Most laboratorians know that Roche sold $430.5 million of its stock holding in Laboratory Corporation of America stock only seven days ago. Lesser known is the fact that LabCorp executives Thomas McMahon and Brad Smith sold a total …

“October 23, 2000 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

;